Advanced Intellectual Property Strategies for Defending Your Life Sciences IPO
The Deal's 2nd half M&A scene: Interview with Spencer Klein, Morrison Foerster
Innovative Exit Strategies for Life Sciences Companies – Interview with Bill Whelan, Member, Mintz Levin
Financing Trends in Life Sciences – Interview with Bill Whelan, Member, Mintz Levin
Polsinelli Podcast - Emerging Technology & Startup Companies
Digital Health: Where is the Action for Entrepreneurs?
Doug Greenburg is a partner at Latham & Watkins and a Vice Chair of the global Litigation Department. His practice focuses on internal corporate investigations, white collar criminal defense, and US Securities and Exchange...more
Welcome to the December 2014 edition of Red Notice, a publication of Akin Gump Strauss Hauer & Feld LLP.
This month on the anticorruption front, a major cosmetics retailer as well as its subsidiary pleads guilty to...more
In This Issue:
- Here Come the Feds -- What President Obama’s second term means for the tech industry
- Log In:
...Feds cast an eye on social media
...3-D’s IP dimension
We are pleased to provide a collection of commentaries on the critical legal issues facing our clients in 2013.
There is hope that global economic and market conditions will continue to improve despite ongoing...more
Spin-off transactions can be beneficial, but they are complicated, time-consuming and expensive, and can trigger lawsuits and other problems for the parent company if not carefully planned and implemented. This Client Alert...more
Back to Top